Ovomemolins: Egg-derived peptides that improved cognitive decline after oral administration in mice.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Ovomemolins: Egg-derived peptides that improved cognitive decline after oral administration in mice.
- Published In:
- FASEB bioAdvances, 6(7), 177-188 (2024)
- Authors:
- Nakajima, Takanobu, Shobako, Maiko, Kaneko, Kentaro, Kurabayashi, Atsushi, Sato, Masaru, Ohinata, Kousaku
- Database ID:
- RPEP-08928
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08928APA
Nakajima, Takanobu; Shobako, Maiko; Kaneko, Kentaro; Kurabayashi, Atsushi; Sato, Masaru; Ohinata, Kousaku. (2024). Ovomemolins: Egg-derived peptides that improved cognitive decline after oral administration in mice.. FASEB bioAdvances, 6(7), 177-188. https://doi.org/10.1096/fba.2023-00149
MLA
Nakajima, Takanobu, et al. "Ovomemolins: Egg-derived peptides that improved cognitive decline after oral administration in mice.." FASEB bioAdvances, 2024. https://doi.org/10.1096/fba.2023-00149
RethinkPeptides
RethinkPeptides Research Database. "Ovomemolins: Egg-derived peptides that improved cognitive de..." RPEP-08928. Retrieved from https://rethinkpeptides.com/research/nakajima-2024-ovomemolins-eggderived-peptides-that
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.